David Arterburn, MD, MPH, is a general internist and health services researcher who focuses on finding safe, effective, and non-stigmatizing ways to treat obesity. As an international leader in obesity research, his goal is to help individuals and families make treatment decisions that align with their values while sustaining their health over the long haul.
Dr. Arterburn's research portfolio includes studies of the impact of neighborhood environments on obesity, mindfulness-based interventions for weight loss, obesity pharmacotherapy, the long-term outcomes of bariatric surgery, and implementation of shared decision making tools and processes. He recently led the PCORnet Bariatric Study, a two-year, $4.5 million study comparing the health benefits and safety associated with the main types of bariatric surgery in 41 health systems in the United States. Funded by the Patient-Centered Outcomes Research Institute (PCORI), the study’s results give patients and their health care providers the information they need to decide which type of surgery is best for them. In July 2019, PCORI awarded Dr. Arterburn an additional $2.1 million to incorporate these new results into shared decision making at Kaiser Permanente Washington and the University of Pittsburgh Medical Center.
Over the past decade, Dr. Arterburn has collaborated with Kaiser Permanente Washington's specialty leadership to implement and evaluate shared decision making with patient decision aids to support elective surgical care. The approach has shown great promise for improving the quality of health care while simultaneously lowering the costs of care in some populations.
Dr. Arterburn collaborates extensively in his research and has federally-funded projects related to obesity and bariatric surgery with investigators at University of Washington (UW), Duke University, Harvard, University of Pittsburgh, University of Michigan, Wake Forest, and the Cleveland Clinic.
Dr. Arterburn joined Kaiser Permanente Washington Health Research Institute in 2006. In recognition of his contributions to science, he has been named an honorary Fellow of the American Society of Metabolic and Bariatric Surgery (FASMBS) and a Fellow of the American College of Physicians (FACP) and The Obesity Society (FTOS). Dr. Arterburn is past chair of the Adult Obesity Measurement Advisory Panel sponsored by the National Committee on Quality Assurance, founding chair of the Obesity Society's Health Services Research Section, and past chair of the Health Care Systems Research Network's Obesity Special Interest Group. In 2013 he co-chaired the National Institutes of Health Symposium on the Long-Term Outcomes of Bariatric Surgery. He is also an affiliate professor in the UW Department of Medicine.
Bariatric surgery; health services research; economics and risk adjustment; pharmaceutical outcomes research
Obesity prevention and control
Pharmaco-epidemiology, pharmacogenetics, pharmaceutical outcomes research
Shared decision making
Obesity prevention and control
Haneuse S, Bogart A, Jazic I, Westbrook EO, Boudreau D, Theis MK, Simon GE, Arterburn D. Learning about missing data mechanisms in electronic health records-based research: a survey-based approach. Epidemiology. 2016 Jan;27(1):82-90. Epub 2015 Oct 19. PubMed
Rosenberg DE, Gell NM, Jones SM, Renz A, Kerr J, Gardiner PA, Arterburn D. The feasibility of reducing sitting time in overweight and obese older adults. Health Educ Behav. 2015 Oct;42(5):669-76. doi: 10.1177/1090198115577378. Epub 2015 Mar 20. PubMed
Jones SM, Rosenberg D, Ludman E, Arterburn D. Medical comorbidity and psychotropic medication fills in older adults with breast or prostate cancer. Support Care Cancer. 2015 Oct;23(10):3005-9. doi: 10.1007/s00520-015-2668-y. Epub 2015 Feb 27. PubMed
Arterburn D, Wood GC, Theis MK, Westbrook EO, Anau J, Rukstalis M, Boscarino JA, Daar Z, Gerhard GS. Antipsychotic medications and extreme weight gain in two health systems. Obes Res Clin Pract. 2015 Sep 8. pii: S1871-403X(15)00126-X. doi: 10.1016/j.orcp.2015.08.012. [Epub ahead of print]. PubMed
Lewis KH, Zhang F, Arterburn DE, Ross-Degnan D, Gillman MW, Wharam JF. Comparing medical costs and use after laparoscopic adjustable gastric banding and Roux-en-Y gastric bypass. JAMA Surg. 2015 Aug;150(8):787-94. doi: 10.1001/jamasurg.2015.1081. PubMed
Several new grants will fund research on effectiveness, safety, and equitable use of anti-obesity medications.
Study uses geographic data to track change over time.
Largest study to date helps patients weigh risks and benefits of surgery.
An evaluation with KPWHRI researchers looked at the impacts of the tax so far.